Peter David Gluckman

Person

Auckland, NZ

People

Patents Grantslast 30 patents

Information Patent Grant
Maternal vitamin B12 administration for the prevention of increased...
- Patent number 11,065,271
- Issue date Jul 20, 2021
- Societe des Produits Nestle S.A.
- Cyrus Cooper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Maternal vitamin B6 administration for the prevention of increased...
- Patent number 10,980,786
- Issue date Apr 20, 2021
- Nestec S.A.
- Cyrus Cooper
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Grant
Maternal vitamin B12 administration for the prevention of increased...
- Patent number 10,517,891
- Issue date Dec 31, 2019
- Societe des Produits Nestle S.A.
- Cyrus Cooper
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Grant
Maternal vitamin B6 administration for the prevention of increased...
- Patent number 9,980,950
- Issue date May 29, 2018
- Nestec S.A.
- Cyrus Cooper
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Grant
Cognitive enhancement and cognitive therapy using glycyl-L-2-methyl...
- Patent number 8,637,567
- Issue date Jan 28, 2014
- Neuren Pharmaceuticals Ltd.
- Peter David Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of non-convulsive seizures in brain injury using G-2-meth...
- Patent number 7,714,020
- Issue date May 11, 2010
- Neuren Pharmaceuticals Limited
- Peter David Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
- Patent number 7,605,177
- Issue date Oct 20, 2009
- Neuren Pharmaceuticals Limited
- Peter David Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neuroprotective effect of growth hormone
- Patent number 7,304,029
- Issue date Dec 4, 2007
- Neuren Pharmaceuticals Ltd.
- Arjan Scheepens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
GPE analogs
- Patent number 7,112,570
- Issue date Sep 26, 2006
- Neuren Pharmaceuticals, Ltd.
- Peter Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Regulation of tyrosine hydroxylase by GPE
- Patent number 6,933,282
- Issue date Aug 23, 2005
- Neuren Pharmaceuticals Ltd.
- Peter D. Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods to improve neural outcome
- Patent number 6,812,208
- Issue date Nov 2, 2004
- NeuronZ Ltd.
- Peter D. Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of GPE to protect glial cells or non-dopaminergic cells from de...
- Patent number 6,780,848
- Issue date Aug 24, 2004
- NeuronZ, Ltd.
- Peter D. Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Regulation of tyrosine hydroxylase
- Patent number 6,617,311
- Issue date Sep 9, 2003
- NeuronZ Limited
- Peter D. Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Regulation of neural enzymes
- Patent number 6,365,573
- Issue date Apr 2, 2002
- Neuronz Ltd.
- Peter D Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TGF-β1 to improve neural outcome
- Patent number 6,204,240
- Issue date Mar 20, 2001
- Genentech, Inc.
- Peter Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods to improve neural outcome
- Patent number 6,187,906
- Issue date Feb 13, 2001
- Aukland Uniservices Limited
- Peter D. Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of catabolic states using authentic IGF-1 and hypocaloric...
- Patent number 6,034,059
- Issue date Mar 7, 2000
- Chiron Corporation
- Linda Fryklund
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating hypertension in pregnant mammals
- Patent number 5,922,673
- Issue date Jul 13, 1999
- Chiron Corporation
- Peter David Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IGF-1 to improve the neural condition
- Patent number 5,861,373
- Issue date Jan 19, 1999
- Genentech, Inc.
- Peter Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fetal growth
- Patent number 5,858,966
- Issue date Jan 12, 1999
- Auckland Uniservices Limited
- Jane Elizabeth Harding
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of human growth hormone for preoperative administration
- Patent number 5,783,560
- Issue date Jul 21, 1998
- Pharmacia & Upjohn Aktiebolag
- Peter Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IFG-1 to improve neural outcome
- Patent number 5,714,460
- Issue date Feb 3, 1998
- Genentech Inc.
- Peter Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of growth factor IGF-I and/or IGF-II
- Patent number 5,710,127
- Issue date Jan 20, 1998
- Pharmacia & Upjohn Aktiebolag
- Peter David Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of growth factor IGF-I or IGF-II
- Patent number 5,534,493
- Issue date Jul 9, 1996
- Pharmacia AB
- Peter D. Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Growth factor IGF-Il
- Patent number 5,482,926
- Issue date Jan 9, 1996
- Pharmacia AB
- Peter D. Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of human IGF-1 to treat cardiac disorders
- Patent number 5,434,134
- Issue date Jul 18, 1995
- Pharmac IA AB
- Peter Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IGF-1 and related compounds in pregnancy
- Patent number 5,420,111
- Issue date May 30, 1995
- Auckland Uniservices Limited
- Peter D. Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of human lactation failure
- Patent number 5,276,014
- Issue date Jan 4, 1994
- Kabi Pharmacia AB
- Peter Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MATERNAL VITAMIN B2 ADMINISTRATION FOR THE PREVENTION OF INCREASED...
- Publication number 20240122935
- Publication date Apr 18, 2024
- SOCIETE DES PRODUITS NESTLE S.A.
- Cyrus Cooper
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
MATERNAL DPA FOR BENEFIT OF MOTHER AND/OR CHILD'S MENTAL HEALTH
- Publication number 20220087964
- Publication date Mar 24, 2022
- AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR)
- Neerja KARNANI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATERNAL VITAMIN B12 ADMINISTRATION FOR THE PREVENTION OF INCREASED...
- Publication number 20200188421
- Publication date Jun 18, 2020
- SOCIETE DES PRODUITS NESTLE S.A.
- Cyrus Cooper
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
MATERNAL VITAMIN B6 ADMINISTRATION FOR THE PREVENTION OF INCREASED...
- Publication number 20180280369
- Publication date Oct 4, 2018
- Nestec S.A.
- Cyrus Cooper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATERNAL VITAMIN B2 ADMINISTRATION FOR THE PREVENTION OF INCREASED...
- Publication number 20170087161
- Publication date Mar 30, 2017
- Nestec S.A.
- Cyrus Cooper
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
MATERNAL VITAMIN B6 ADMINISTRATION FOR THE PREVENTION OF INCREASED...
- Publication number 20160324841
- Publication date Nov 10, 2016
- Nestec S.A.
- Cyrus Cooper
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
MATERNAL VITAMIN B12 ADMINISTRATION FOR THE PREVENTION OF INCREASED...
- Publication number 20160317565
- Publication date Nov 3, 2016
- Nestec S.A.
- Cyrus Cooper
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
SYSTEM AND METHOD FOR PARAMETER ESTIMATION IN BIOLOGICAL PROCESSES
- Publication number 20120232804
- Publication date Sep 13, 2012
- AUCKLAND UNISERVICES LIMITED, a New Zealand Co.
- Anthony Bryan Pleasants
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
PREDICTIVE USE OF CpG METHYLATION
- Publication number 20120040344
- Publication date Feb 16, 2012
- Keith Malcolm Godfrey
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COGNITIVE ENHANCEMENT AND COGNITIVE THERAPY USING GLYCYL-L-2-METHYL...
- Publication number 20110112033
- Publication date May 12, 2011
- Peter David Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHENOTYPE PREDICTION
- Publication number 20090104615
- Publication date Apr 23, 2009
- Keith Malcolm Godfrey
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
- Publication number 20070298009
- Publication date Dec 27, 2007
- NEUREN PHARMACEUTICALS LIMITED
- Peter David Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Neuroprotective Effects of Gly-Pro-Glu Following Intravenous Infusion
- Publication number 20070224165
- Publication date Sep 27, 2007
- NEUREN PHARMACEUTICALS LIMITED
- Jian Guan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Neuroprotective effect of activin in animals exposed to hypoxia/isc...
- Publication number 20070015707
- Publication date Jan 18, 2007
- Neuren Pharmaceuticals Limited
- Peter David Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cognitive enhancement and cognitive therapy using glycyl-L-2-methyl...
- Publication number 20070004641
- Publication date Jan 4, 2007
- NEUREN PHARMACEUTICALS LIMITED
- Peter David Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Somatogenic therapy using a 20kda placental variant of growth hormone
- Publication number 20060281675
- Publication date Dec 14, 2006
- NEUREN PHARMACEUTICALS LIMITED
- Peter Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of non-convulsive seizures in brain injury using G-2-meth...
- Publication number 20060251649
- Publication date Nov 9, 2006
- Neuren Pharmaceuticals Limited
- Peter David Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hypertenson treatment
- Publication number 20040248788
- Publication date Dec 9, 2004
- Mark Hedley Vickers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REGULATION OF TYROSINE HYDROXYLASE BY GPE
- Publication number 20040087487
- Publication date May 6, 2004
- Peter D. Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Gpe analogs
- Publication number 20040014674
- Publication date Jan 22, 2004
- Peter Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Neuronal rescue agent
- Publication number 20030060398
- Publication date Mar 27, 2003
- Peter David Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Composition and methods to improve neural outcome
- Publication number 20030027760
- Publication date Feb 6, 2003
- Peter David Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGF-beta to improve neural outcome
- Publication number 20030004108
- Publication date Jan 2, 2003
- Genentech, Inc.
- Peter Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods to improve neural outcome
- Publication number 20020035066
- Publication date Mar 21, 2002
- Peter D. Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Composition and methods to improve neural outcome
- Publication number 20020013277
- Publication date Jan 31, 2002
- Peter D. Gluckman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Peter David Gluckman

Person

Patents Grantslast 30 patents

Maternal vitamin B12 administration for the prevention of increased...

Maternal vitamin B6 administration for the prevention of increased...

Maternal vitamin B12 administration for the prevention of increased...

Maternal vitamin B6 administration for the prevention of increased...

Cognitive enhancement and cognitive therapy using glycyl-L-2-methyl...

Treatment of non-convulsive seizures in brain injury using G-2-meth...

Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration

Neuroprotective effect of growth hormone

GPE analogs

Regulation of tyrosine hydroxylase by GPE

Methods to improve neural outcome

Use of GPE to protect glial cells or non-dopaminergic cells from de...

Regulation of tyrosine hydroxylase

Regulation of neural enzymes

TGF-&#x03B2;1 to improve neural outcome

Methods to improve neural outcome

Treatment of catabolic states using authentic IGF-1 and hypocaloric...

Method of treating hypertension in pregnant mammals

IGF-1 to improve the neural condition

Fetal growth

Use of human growth hormone for preoperative administration

IFG-1 to improve neural outcome

Use of growth factor IGF-I and/or IGF-II

Use of growth factor IGF-I or IGF-II

Growth factor IGF-Il

Use of human IGF-1 to treat cardiac disorders

IGF-1 and related compounds in pregnancy

Treatment of human lactation failure

Patents Applicationslast 30 patents

MATERNAL VITAMIN B2 ADMINISTRATION FOR THE PREVENTION OF INCREASED...

MATERNAL DPA FOR BENEFIT OF MOTHER AND/OR CHILD'S MENTAL HEALTH

MATERNAL VITAMIN B12 ADMINISTRATION FOR THE PREVENTION OF INCREASED...

MATERNAL VITAMIN B6 ADMINISTRATION FOR THE PREVENTION OF INCREASED...

MATERNAL VITAMIN B2 ADMINISTRATION FOR THE PREVENTION OF INCREASED...

MATERNAL VITAMIN B6 ADMINISTRATION FOR THE PREVENTION OF INCREASED...

MATERNAL VITAMIN B12 ADMINISTRATION FOR THE PREVENTION OF INCREASED...

SYSTEM AND METHOD FOR PARAMETER ESTIMATION IN BIOLOGICAL PROCESSES

PREDICTIVE USE OF CpG METHYLATION

COGNITIVE ENHANCEMENT AND COGNITIVE THERAPY USING GLYCYL-L-2-METHYL...

PHENOTYPE PREDICTION

Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration

Neuroprotective Effects of Gly-Pro-Glu Following Intravenous Infusion

Neuroprotective effect of activin in animals exposed to hypoxia/isc...

Cognitive enhancement and cognitive therapy using glycyl-L-2-methyl...

Somatogenic therapy using a 20kda placental variant of growth hormone

Treatment of non-convulsive seizures in brain injury using G-2-meth...

Hypertenson treatment

REGULATION OF TYROSINE HYDROXYLASE BY GPE

Gpe analogs

Neuronal rescue agent

Composition and methods to improve neural outcome

TGF-beta to improve neural outcome

Methods to improve neural outcome

Composition and methods to improve neural outcome

TGF-β1 to improve neural outcome